Xiaojing Wang
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Immunology top 5%
- Psoriasis: Treatment and Pathogenesis
Papers in
- Epidemiology 24
- Liver Disease Diagnosis and Treatment 14
- Hepatitis B Virus Studies 9
- Co-authors
- Qin Ning (28 shared papers)Kai Huang (13 shared papers)Liduan Zheng (17 shared papers)Qiangsong Tong (17 shared papers)Xin‐Hua Feng (1 shared paper)Allen G. Li (1 shared paper)Donna Wang (1 shared paper)Huajie Song (11 shared papers)
- Journals
- Journal of Enzyme Inhibition and Medicinal Chemistry (5 papers)Oncogene (4 papers)Liver International (3 papers)Materials Letters (2 papers)Frontiers in Microbiology (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Xiaojing Wang
103 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 138
- Cancer Research 562
- Immunology 542
- Hepatology 170
- Molecular Biology 1.1k
- Epidemiology 472
Countries citing papers authored by Xiaojing Wang
This map shows the geographic impact of Xiaojing Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojing Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojing Wang more than expected).
Fields of papers citing papers by Xiaojing Wang
This network shows the impact of papers produced by Xiaojing Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojing Wang. The network helps show where Xiaojing Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaojing Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 215 | |
| 2 | 2021 | 191 | |
| 3 | 2004 | 180 | |
| 4 | 2019 | 128 | |
| 5 | 2018 | 117 | |
| 6 | 2009 | 109 | |
| 7 | 2010 | 99 | |
| 8 | 2020 | 89 | |
| 9 | 2019 | 88 | |
| 10 | 2018 | 88 | |
| 11 | 2018 | 79 | |
| 12 | 2022 | 59 | |
| 13 | 2022 | 57 | |
| 14 | 2013 | 54 | |
| 15 | 2021 | 53 | |
| 16 | 2007 | 53 | |
| 17 | 2018 | 51 | |
| 18 | 2022 | 49 | |
| 19 | 2009 | 49 | |
| 20 | 2012 | 48 |
About Xiaojing Wang
Xiaojing Wang is a scholar working on Molecular Biology, Epidemiology, Immunology, Cancer Research and Neurology, having authored 103 papers that have together received 3.0k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (14 papers), Neuroblastoma Research and Treatments (11 papers), Hepatitis B Virus Studies (9 papers), Cancer, Hypoxia, and Metabolism (9 papers), Cancer-related molecular mechanisms research (6 papers), Immune Cell Function and Interaction (5 papers), Psoriasis: Treatment and Pathogenesis (4 papers) and T-cell and B-cell Immunology (4 papers). The work is most often cited by research in Cancer Research (562 citations), Immunology (542 citations), Hepatology (170 citations), Molecular Biology (1.1k citations) and Epidemiology (472 citations). Xiaojing Wang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Qin Ning, Kai Huang, Liduan Zheng, Qiangsong Tong, Xin‐Hua Feng, Allen G. Li, Donna Wang, Huajie Song, Erhu Fang and Weiming Yan. Their work appears in journals such as Journal of Enzyme Inhibition and Medicinal Chemistry, Oncogene, Liver International, Materials Letters and Frontiers in Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.